Connected Health Personal Medical Devices Market Report 2026

Connected Health Personal Medical Devices Market Overview

• Connected Health Personal Medical Devices market size has reached to $45.71 billion in 2025 • Expected to grow to $91.9 billion in 2030 at a compound annual growth rate (CAGR) of 14.9% • Growth Driver: Rising Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Increasing Demand For Continuous Health Monitoring • Market Trend: Advanced Urine Monitoring Solution Promotes Preventive Healthcare • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Connected Health Personal Medical Devices Market?

Connected health personal medical devices are smart medical tools designed to monitor, track, and transmit health data from individuals to healthcare providers in real time. These devices integrate technologies such as sensors, wireless communication, and mobile apps to enable continuous, remote health monitoring. Their main purpose is to enhance patient engagement, support early diagnosis, and improve chronic disease management outside traditional clinical settings. The main types of connected health personal medical devices are healthcare IT, health information exchange, and healthcare analytics. Healthcare IT refers to the integration of information technology in the healthcare sector to improve patient outcomes, streamline workflows, and enhance data security. The various products used include insulin pumps, BP monitors, portable GPS PERS, glucose monitors, personal pulse oximeters, smart pill dispensers, and personal ECG devices. These devices utilize various connectivities, such as bluetooth, Wi-Fi, cellular, and others, and are used across diverse applications, including chronic disease management, fitness and wellness, home healthcare, and others, serving a range of end users, including hospitals, clinics, homecare settings, and others.

What Is The Connected Health Personal Medical Devices Market Growth Forecast?

The connected health personal medical devices market size is expected to see rapid growth in the next few years. It will grow to $91.9 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to rapid development of smart wearable medical devices, expansion of home healthcare solutions, increasing integration with cloud-based health platforms, rising patient engagement in self-monitoring, adoption of predictive and real-time analytics for personalized care. Major trends in the forecast period include rising adoption of remote patient monitoring devices, integration of wearable health technologies with mobile apps, increasing use of smart pill dispensers and glucose monitors, focus on chronic disease management and preventive care, expansion of telemedicine and home healthcare services.

Global Connected Health Personal Medical Devices Market Segmentation

1) By Solution: Healthcare IT, Health Information Exchange, Healthcare Analytics 2) By Product: Insulin Pumps, Blood Pressure (BP) Monitors, Portable Global Positioning System (GPS) Personal Emergency Response System (PERS), Glucose Monitor, Personal Pulse Oximeter, Smart Pill Dispenser, Personal Electrocardiogram (ECG) 3) By Connectivity: Bluetooth, Wi-Fi, Cellular, Other Connectivities 4) By Application: Chronic Disease Management, Fitness And Wellness, Home Healthcare, Other Applications 5) By End User: Hospitals, Clinics, Homecare Settings, Other End Users Subsegments: 1) By Healthcare IT: Electronic Health Records (EHR), Telemedicine Solutions, Mobile Health (mHealth) Applications, E-Prescribing Systems 2) By Health Information Exchange: Directed Exchange, Query-Based Exchange, Consumer-Mediated Exchange, Cloud-Based Health Information Platforms 3) By Healthcare Analytics: Descriptive Analytics, Predictive Analytics, Prescriptive Analytics, Real-Time Analytics

What Is The Driver Of The Connected Health Personal Medical Devices Market?

The rising prevalence of chronic diseases is expected to propel the growth of the connected health personal medical devices market going forward. Chronic diseases are persistent health conditions that develop slowly and last for an extended period, often requiring continuous medical care. The growing prevalence of chronic diseases is partly due to inactive lifestyles, as prolonged sitting and minimal physical activity raise the risk of diseases such as heart conditions and diabetes. Connected health personal medical devices aid in chronic disease monitoring by enabling real-time health tracking, making them ideal for managing conditions such as diabetes and hypertension at home. They reduce the need for frequent clinic visits by providing continuous data and timely alerts, improving patient outcomes and convenience. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the growth of the connected health personal medical devices industry.

Key Players In The Global Connected Health Personal Medical Devices Market

Major companies operating in the connected health personal medical devices market are Johnson and Johnson, F Hoffmann La Roche AG, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Becton Dickinson and Company, GE HealthCare, Philips Healthcare, Omron Healthcare, Masimo Corporation, Oura Health Oy, Whoop Inc, Withings, Eko Health Inc, TytoCare Ltd, AliveCor Inc, DarioHealth Corp, iHealth Labs Inc, Samsung Electronics, Biostrap, Aktiia, Ava Science Inc, Bloomlife Inc, Movano Health, Oxitone Medical Ltd, Qardio Inc

Global Connected Health Personal Medical Devices Market Trends and Insights

Major companies operating in the connected health personal medical devices market are focusing on developing advanced products, such as advanced in-home diagnostic systems, to improve preventive healthcare and user convenience. In-home diagnostic systems refer to medical devices and tools that allow individuals to monitor, test, and manage their health conditions at home without needing to visit a healthcare facility. For instance, in January 2023, Withings, a France-based health technology company, launched U-Scan, a hands-free, in-home urine analysis system designed to fit inside a toilet bowl. It uses a replaceable cartridge that performs daily tests for up to three months, analyzing key hydration and nutrition biomarkers. The device connects to a smartphone app, providing users with real-time insights and personalized health recommendations. U-Scan aims to make routine health tracking seamless and non-invasive, promoting proactive wellness management.

What Are Latest Mergers And Acquisitions In The Connected Health Personal Medical Devices Market?

In September 2024, Veridian Healthcare LLC, a US-based medical devices company, acquired Zewa Inc. for an undisclosed amount. With this acquisition, Veridian Healthcare significantly broadened its remote patient monitoring and telehealth product portfolio, particularly enhancing its respiratory device portfolio. Zewa Inc. is a US-based medical device company specializing in connected health monitoring devices.

Regional Outlook

North America was the largest region in the connected health personal medical devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Connected Health Personal Medical Devices Market?

The connected health personal medical devices market consists of revenues earned by entities by providing services such as remote patient monitoring, real-time health data analytics, telehealth integration, personalized health alerts and recommendations, cloud-based health data storage, device maintenance and support, and mobile health application management. The market value includes the value of related goods sold by the service provider or included within the service offering. The connected health personal medical devices market also includes sales of wearable fitness trackers, smartwatches with health monitoring features, smart thermometers, digital inhalers, and other internet of things (IoT)-enabled diagnostic and therapeutic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.